companydata.dkcompanydata.dk

Vericel Denmark ApS: Financial statements 2014

CVR: 19740986

Source: annual report 2014, Danish Business Authority

01/01/2014 – 31/12/2014

Vericel Denmark ApS (CVR 19740986) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 3,321,009 and a net result of DKK -13,614,809 compared with DKK -4,215,411 the year before. That is a decrease of 94% compared with the year before. Equity in the 2014 report amounted to DKK 7,576,195. The solvency ratio was 60.9%.

Gross Profit
DKK 3,321,009
Profit/Loss
DKK -13,614,809
Equity
DKK 7,576,195
Total Assets
DKK 12,446,891

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2014-3.3 mio.-13.6 mio.7.6 mio.-
2013-55.1 mio.-4.2 mio.33 mio.-
2012-23.5 mio.3.7 mio.37.2 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2014

Vericel Denmark ApS appoints new auditorOct 10, 2014

As of October 10, 2014, EY Godkendt Revisionspartnerselskab has been appointed auditor of Vericel Denmark ApS.

Auditor steps down at Vericel Denmark ApSOct 10, 2014

As of October 10, 2014, JUT NR. 2180 A/S has stepped down as auditor of Vericel Denmark ApS.

GENZYME BIOSURGERY ApS changes name to AASTROM BIOSCIENCES DK ApSJul 30, 2014

On July 30, 2014, the company changed its name from GENZYME BIOSURGERY ApS to AASTROM BIOSCIENCES DK ApS.

Birthe Davidsen steps down as director of Vericel Denmark ApSJul 4, 2014

As of July 4, 2014, Birthe Davidsen has stepped down as director of Vericel Denmark ApS.

Kirstin Jagd leaves the board of Vericel Denmark ApSMay 30, 2014

As of May 30, 2014, Kirstin Jagd has left the board of directors of Vericel Denmark ApS.

Birthe Davidsen leaves the board of Vericel Denmark ApSMay 30, 2014

As of May 30, 2014, Birthe Davidsen has left the board of directors of Vericel Denmark ApS.

Lasse Richter Petersen leaves the board of Vericel Denmark ApSMay 30, 2014

As of May 30, 2014, Lasse Richter Petersen has left the board of directors of Vericel Denmark ApS.

Gerard Joseph Michel joins Vericel Denmark ApS as directorMay 30, 2014

As of May 30, 2014, Gerard Joseph Michel is registered as director of Vericel Denmark ApS.

Registered as owner of Vericel Denmark ApSMay 30, 2014

As of May 30, 2014, is registered as an owner of Vericel Denmark ApS with an ownership share of 100%.

Vericel Denmark ApS: The 2013 annual report is outMay 7, 2014

Vericel Denmark ApS has published its annual report for 2013. Gross profit came to DKK 55,064,189, and the net result was DKK -4,215,411.

About Vericel Denmark ApS

Vericel Denmark ApS is a Danish company of the type Anpartsselskab based in Glostrup, founded in 1996. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named AASTROM BIOSCIENCES DK ApS and GENZYME BIOSURGERY ApS. The management consists of Joseph Anthony Mara Jr. The company is owned by Vericel Corporation. The company has 0 employees (2015). In 2025, the company reported a gross profit of DKK -128,481 and a net result of DKK -128,481 compared with DKK -109,464 the year before. Equity in the 2025 report amounted to DKK 6,241,335.

Source: annual report 2025, Danish Business Authority